Modern Care Journal
Sun, Aug 2, 2026
[Archive]
Volume 23, Issue 2 (6-2026)
|
Back to browse issues page
Ethics code: IR.BUMS.REC.1401.251
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mohammadi M, Namaei M H, Ashrafipour M, Abdolahi Ziaaldini M A, Nikoomanesh F. Prevalence, Antifungal Susceptibility, and Biofilm-Forming Ability of Candida Species from Clinical Samples. Mod Care J 2026; 23 (2) :18-25
URL: http://mcj.bums.ac.ir/article-1-618-en.html
URL: http://mcj.bums.ac.ir/article-1-618-en.html
Mahdi Mohammadi1 
, Mohammad Hassan Namaei2 , Mostafa Ashrafipour3 , Mohammad Amin Abdolahi Ziaaldini1 , Fatemeh Nikoomanesh *4
, Mohammad Hassan Namaei2 , Mostafa Ashrafipour3 , Mohammad Amin Abdolahi Ziaaldini1 , Fatemeh Nikoomanesh *4
1- Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran.
2- Department of Laboratory Sciences, Faculty of Paramedical and Rehabilitation Sciences, Mashhad University of Medical Sciences, Mashhad, Iran.
3- Department of Parasitology and Mycology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashahad, Iran.
4- Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran. ,fateme.nikoomanesh@bums.ac.ir
2- Department of Laboratory Sciences, Faculty of Paramedical and Rehabilitation Sciences, Mashhad University of Medical Sciences, Mashhad, Iran.
3- Department of Parasitology and Mycology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashahad, Iran.
4- Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran. ,
Abstract: (73 Views)
Introduction: Candida species, as opportunistic fungal pathogens, can form biofilms on biotic and abiotic surfaces, leading to resistance to current antifungals used in the treatment of candidiasis. This study aimed to identify Candida species from clinical samples and to assess antifungal susceptibility patterns and biofilm-forming ability.
Objective: This study aimed to identify different Candida species from clinical samples and to assess the antifungal susceptibility patterns and biofilm formation ability.
Methods: In this study, 100 Candida isolates were obtained from various clinical samples (blood, urine, body fluids, etc.) by culturing. Antifungal susceptibility assays for Candida isolates were performed using the broth microdilution technique in accordance with the Clinical and Laboratory Standards Institute M27-A3/S4 guidelines. Biofilm formation was measured by the colorimetric microtiter method.
Results: Candida albicans (48%) was the most common Candida species identified, followed by C. glabrata (34%), C. dubliniensis (9%), C. tropicalis (5%), C. parapsilosis (1%), C. krusei (1%), and two mixed colonies were identified. The antifungal susceptibility pattern shows that Candida isolates exhibit varying susceptibilities. C. albicans was 100% susceptible to amphotericin B, whereas C. glabrata was 70.58% resistant to amphotericin B. The Candida parapsilopsis isolate was susceptible to all antifungals. According to the results, Candida isolates have a moderate ability to form biofilms.
Conclusion: Therefore, periodic monitoring of Candida species prevalence and antifungal susceptibility patterns necessitates selecting the appropriate therapeutic protocol, as well as the development of novel antifungal compounds and treatment strategies.
Objective: This study aimed to identify different Candida species from clinical samples and to assess the antifungal susceptibility patterns and biofilm formation ability.
Methods: In this study, 100 Candida isolates were obtained from various clinical samples (blood, urine, body fluids, etc.) by culturing. Antifungal susceptibility assays for Candida isolates were performed using the broth microdilution technique in accordance with the Clinical and Laboratory Standards Institute M27-A3/S4 guidelines. Biofilm formation was measured by the colorimetric microtiter method.
Results: Candida albicans (48%) was the most common Candida species identified, followed by C. glabrata (34%), C. dubliniensis (9%), C. tropicalis (5%), C. parapsilosis (1%), C. krusei (1%), and two mixed colonies were identified. The antifungal susceptibility pattern shows that Candida isolates exhibit varying susceptibilities. C. albicans was 100% susceptible to amphotericin B, whereas C. glabrata was 70.58% resistant to amphotericin B. The Candida parapsilopsis isolate was susceptible to all antifungals. According to the results, Candida isolates have a moderate ability to form biofilms.
Conclusion: Therefore, periodic monitoring of Candida species prevalence and antifungal susceptibility patterns necessitates selecting the appropriate therapeutic protocol, as well as the development of novel antifungal compounds and treatment strategies.
Article Types: Research Article |
Subject:
General
Received: 2026/04/12 | Accepted: 2026/06/20 | Published: 2026/06/30
Received: 2026/04/12 | Accepted: 2026/06/20 | Published: 2026/06/30
References
1. 1. Pristov KE, Ghannoum MA. Resistance of Candida to azoles and echinocandins worldwide. Clin Microbiol Infect. 2019;25(7):792-798. [PMID: 30965100.] [DOI:10.1016/j.cmi.2019.03.028]
2. Ghasemi R, Rabiei MM, Lotfali E, AbolghasemiS, Ansari S. Candiduria: Prevalence, Identification of Isolated Candida Species and Trends in Antifungal Susceptibility in Hospitalized Patients. Nov Biomed. 2020;8(2):71-8. [DOI:10.22037/nbm. v1i1.26963]
3. Xiao M, Chen SC, Kong F, Xu XL, Yan L, Kong HS, et al. Distribution and antifungal susceptibility of candida species causing candidemia in China: An update from the CHIF-NET Study. J Infect Dis. 2020 Mar 16 (Supplement_2);221: 136-47. [PMID: 32176789.] [DOI:10.1093/infdis/jiz573]
4. Waikhom SD, Afeke I, Kwawu GS, Mbroh HK, Osei GY, Louis B, et al. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: Species identification and antifungal susceptibility of Candida isolates. BMC Pregnancy Childbirth. 2020;20(1): 266. [ PMID: 32375724; PMCID: PMC7201979.] [DOI:10.1186/s12884-020-02963-3]
5. Tsega A, Mekonnen F. Prevalence, risk factors and antifungal susceptibility pattern of Candida species among pregnant women at Debre Markos Referral Hospital, Northwest Ethiopia. BMC Pregnancy Childbirth. 2019 Dec 30;19(1):527. [PMID: 31888537; PMCID: PMC6937829.] [DOI:10.1186/s12884-019-2494-1]
6. Soni S, dube A, Verma A, Gupta K, Gupta J, Saini A, et al. Neourodynamics in patient with Alzheimer's disease during working memory task. Sch J Appl Med Sci. 2017;5(8):3257-63. [DOI:10.36347/SJAMS]
7. Deorukhkar SC, Roushani S. Identification of Candida species: conventional methods in the era of molecular diagnosis. Ann Microbiol Immunol. 2018;1(1):1002 [URL: https://www.remedypublications.com/open-access/identification-of-candida-species-conventional-methods-in-the-era-of-molecular-diagnosis-775.pdf]
8. Fuller J, Dingle TC, Bull A, Shokoples S, Laverdière M, Baxter MR, et al. Species distribution and antifungal susceptibility of invasive Candida isolates from Canadian hospitals: results of the CANWARD 2011-16 study. J Antimicrob Chemother. 2019 Aug;74(Suppl 4):48-54. [PMID: 31505645.] [DOI:10.1093/jac/dkz287]
9. Azeredo J, Azevedo NF, Briandet R, Cerca N, Costa AR, Desvaux M, et al. Critical review on biofilm methods. Crit Rev Microbiol.2017 May;7 43(3):313-351. [PMID: 27868469.] [DOI:10.1080/1040841X.2016.1208146]
10. Donlan RM. Biofilm Formation: A Clinically Relevant Microbiological Process. Clin Infect Dis. 2001 Oct 15;33 (8):1387-92. [PMID: 11565080.] [DOI:10.1086/322972]
11. ElFeky DS, Gohar NM, El-Seidi EA, Ezzat MM, AboElew SH. Species identification and antifungal susceptibility pattern of Candida isolates in cases of vulvovaginal candidiasis. Alexandria J Med. 2016;52(3):269-77. [DOI:10.1016/j.ajme.2015.10.001]
12. Mahmoudi Rad M, Zafarghandi S, Abbasabadi B, Tavallaee M. The epidemiology of Candida species associated with vulvovaginal candidiasis in an Iranian patient population. Eur J Obstet Gynecol Reprod Biol. 2011 Apr;155(2):199-203. [PMID: 21194828.] [DOI:10.1016/j.ejogrb.2010.11.022]
13. Arastehfar A, Fang W, Pan W, Lackner M, Liao W, Badiee P, et al. YEAST PANEL multiplex PCR for identification of clinically important yeast species: stepwise diagnostic strategy, useful for developing countries. Diagn Microbiol Infect Dis. 2019 Feb ;93(2):112-9. [PMID: 30377018.] [DOI:10.1016/j.diagmicrobio.2018.09.007]
14. Taira CL, Okay TS, Delgado AF, Ceccon ME, de Almeida MT, Del Negro GM. A multiplex nested PCR for the detection and identification of Candida species in blood samples of critically ill paediatric patients. BMC Infect Dis. 2014 Jul;14(1):406. [ PMID: 25047415; PMCID: PMC4223582.] [DOI:10.1186/1471-2334-14-406]
15. ZARE BM, Ghasemi F, Ghanbarzadeh N, Noferesti F, Nikoomanesh F. Using Single Multiplex PCR Reaction to Identi - fy Candida Species in Vaginal iso - lates: Comparison between Phe - notypic and Molecular Methods. Infect Epidemiol Mi - crobiology. 2022;8(4):337-44. [DOI:10.52547/iem.8.4.337]
16. Nikoomanesh F, Roudbarmohammadi S, Khoobi M, Haghighi F, Roudbary M. Design and synthesis of mucoadhesive nanogel containing farnesol: investigation of the effect on HWP1, SAP6 and Rim101 genes expression of Candida albicans in vitro. Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):64-72. [PMID: 30663419.] [DOI:10.1080/21691401.2018.1543193]
17. Sriphannam C, Nuanmuang N, Saengsawang K, Amornthipayawong D, Kummasook A. Anti-fungal susceptibility and virulence factors of Candida spp. isolated from blood cultures. J Mycol Med. 2019 Dec;29(4):325-30. [ PMID: 31447236.] [DOI:10.1016/j.mycmed.2019.08.001]
18. Khadka S, Sherchand JB, Pokhrel BM, Parajuli K, Mishra SK, Sharma S, et al. Isolation, speciation and antifungal susceptibility testing of Candida isolates from various clinical specimens at a tertiary care hospital, Nepal. BMC Res Notes. 2017 Jun ;10(1):218 [PMID: 28646915; PMCID: PMC5483268.] [DOI:10.1186/s13104-017-2547-3]
19. Seyoum E, Bitew A, Mihret A. Distribution of Candida albicans and non-albicans Candida species isolated in different clinical samples and their in vitro antifungal suscetibity profile in Ethiopia. BMC Infect Dis. 2020 Mar;20(1):231. [ PMID: 32188422; PMCID: PMC7081544.] [DOI:10.1186/s12879-020-4883-5]
20. Hoseinpoor M, Rashki Ghalehnoo Z, TadjrobehkarO. Antifungal Susceptibility of Candida Species Isolated from Admitted Patients with Candiduria in Amir Al-Momenin Hospital, Zabol. J Jiroft Univ Med Sci. 2019;5(2):75-86. [URL: http://journal.jmu.ac.ir/article-1-241-en.html]
21. Yücesoy M, Marol S. Performance of CHROMAGAR candida and BIGGY agar for identification of yeast species. Ann Clin Microbiol Antimicrob. 2003 Oct ;2(1):8. [PMID: 14613587; PMCID: PMC280667.] [DOI:10.1186/1476-0711-2-8]
22. Rezaei H, Foroughi-Parvar F, Maghsood A, Fallah M, Saidijam M, Matini M. Prevalence of bacterial vaginosis and vaginal candidiasis in women presenting to healthcare centers of Hamadan City, West of Iran. Pars J Med Sci. 2022;15(2):17-23. (Persian). [DOI:10.29252/jmj.15.2.17]
23. Ahmad A, Khan AU. Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, Indiae. Eur J Obstet Gynecol Reprod Biol. 2009 May;144(1):68-71. [PMID: 19261369.] [DOI:10.1016/j.ejogrb.2008.12.020]
24. Modiri M, Hashemi SJ, Ghazvini RD, Khodavaisy S, Ahmadi A, Ghaffari M, et al. Antifungal susceptibility pattern and biofilm-related genes expression in planktonic and biofilm cells of Candida parapsilosis species complex. Curr Med Mycol. 2019;5(4):35-42. [PMID: 32104742; PMCID: PMC7034785.] [DOI:10.18502/cmm.5.4.1950]
25. Marak MB, Dhanashree B. Antifungal susceptibility and biofilm production of candida spp. Isolated from clinical samples. Int J Microbiol. 2018 Oct ;2018(1): 7495218. [PMID: 30405717; PMCID: PMC6199855.] [DOI:10.1155/2018/7495218]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
